- Webinar
How GLP-1 Drugs are Reshaping Beauty Standards and Cosmetic Culture
GLP-1 adoption is reshaping how consumers perceive their bodies, navigate daily routines, and engage with beauty and cosmetics brands. Join us for an expert-led session on where disruption is emerging now, what unmet needs are becoming visible, and how companies can respond with stronger portfolio, reformulation, and innovation decisions.
Date : 13 August 2026
Time Slot : 9:30 AM EDT | 3:30 PM CEST | 7:00 PM IST
Format : Virtual session with live insights and Q&A
For skincare brands, color cosmetics teams, aesthetic clinics, ingredient suppliers, fragrance houses, and investors navigating the next shift in beauty demand.
Register Now
- Your joining link will be sent to the email you register with.
Why this conversation matters now
The new opportunity in beauty and cosmetics culture did not begin with a runway moment, a formulation lab breakthrough, or a short-lived social trend. It emerged quietly through a hormone, a weekly injection, and bodies undergoing rapid change.
Drugs such as Ozempic and Wegovy were developed for blood sugar management and weight reduction, yet their effects now extend well beyond those outcomes. As food habits shift, many users are also reporting changes such as skin laxity, visible skin changes, hair thinning, and greater scent sensitivity.
For brands, clinics, suppliers, and investors, this creates a new decision window. The question is no longer whether GLP-1 is influencing beauty routines, but how quickly companies can translate early signals into sharper portfolio choices, smarter reformulation strategies, and more relevant innovation pipelines.
As GLP-1 usage accelerates, brands and providers who move early on messaging, formulation, and patient education will define how this category is trusted and adopted over the next five years.
What attendees will get
- A clear view of where GLP-1 is already disrupting beauty demand and product expectations.
- Practical insight into white-space opportunities across skincare, body care, fragrance, and adjacent formats.
- A structured perspective on whether to reposition existing formulas or invest in new development.
- Strategic guidance for the next 12–18 months to stay commercially relevant.
Five themes, one decision window
-
1
Portfolio strategies for a GLP-1 world
With 1 out of 8 US adults on GLP-1 drugs and adoption accelerating globally, which effects should be targeted, and what products can be built for this new consumer reality?
-
2
Addressing the unmet need
With 82% of GLP-1 users concerned about loose skin and firmness, and users reporting unexpected changes across the body, which beauty formats and zone-specific solutions are best positioned to meet these needs?
-
3
Smart reformulation vs. trend-chasing
Although the first wave of product launches appeared in 2025-26, the market already offers products relevant to GLP-1 users. Will future activity likely focus on reformulating and repositioning existing formulas, or on developing new ones?
-
4
Move beyond just physical recovery
Is physical recovery the only way to support emotional adjustment and self-connection, or will moving beyond it resonate more strongly with this audience?
-
5
The 12–18 month decision window
Leaders who act now could gain an early-mover advantage in a market that is reshaping billions of dollars in annual spending and make decisions to avoid long-term losses and risks to brand relevance.
Our People
Ashu Verma
Ashu Verma brings over 12 years of experience in the consumer packaged goods industry and leads this segment at Stellarix. Ashu works closely with global clients to accelerate innovation, strengthen operations, and shape future-ready strategies. With expertise in market intelligence, trend scouting, and innovation consulting, Ashu supports sustainable growth, product development, and emerging technology decisions for Fortune 500 companies and high-growth businesses.
Sayan Mondal
Sayan Mondal is an IP, technology, and business consulting professional with more than five years of experience delivering innovation and strategic intelligence across beauty and personal care, cosmetics, pharmaceuticals, household care, fragrance and perfumery, and specialty chemicals. Drawing on a background in chemistry and pharmaceutical sciences, Sayan translates complex scientific, technical, and market signals into actionable recommendations for R&D, innovation, new product development, and strategic business decisions.
Client Success Stories Highlighting How Our
Customized Consulting Solutions Contributed To Their Success & Growth
Defining Client Success: How Our Strategic Advisory Turns Complexity into Clarity”
Secure your place in the discussion shaping the next phase of beauty innovation
If your team is evaluating emerging consumer needs, reassessing product relevance, or identifying where to invest next, this webinar will give you a sharper view of what GLP-1 means for the beauty and cosmetics ecosystem.